Yoshiro Hori
Directeur/Membre du Conseil chez JTC INC.
Fortune : 299 804 $ au 30/06/2024
Profil
Yoshiro Hori is the founder of Hori & Co., which was founded in 2005.
He holds the title of President at Hori & Co. Mr. Hori's current job(s) include being a Non-Executive Outside Director at JTC, Inc. since 2011, a Representative Director at Fukuoka Audit Corp.
since 2000, a Director at Fukuoka University since 2014, and an Auditor at Aqumen Biopharmaceuticals KK.
Mr. Hori's former job(s) include being an Outside Director at JM Technology, Inc. and an Auditor at AQUA Therapeutics Co., Ltd.
Mr. Hori obtained his undergraduate degree from Kyushu University in 1987.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
JTC, INC.
inf% | 29/02/2024 | 76 000 ( inf% ) | 299 804 $ | 30/06/2024 |
Postes actifs de Yoshiro Hori
Sociétés | Poste | Début |
---|---|---|
JTC INC. | Directeur/Membre du Conseil | 01/05/2019 |
Aqumen Biopharmaceuticals KK
Aqumen Biopharmaceuticals KK Pharmaceuticals: MajorHealth Technology Aqumen Biopharmaceuticals KK is a holding company that provides research and development of therapeutic medicines for macular degeneration. It also develops therapeutics for diabetic retinopathy, diabetic nephropathy, adjuvants for ophthalmic surgery, and intraocular drug delivery systems. The firm's products encompass the ILM-Blue and the MembraneBlue-Dual. The company was founded by Kimihiko Fujisawa and Tadahisa Kagimoto on April 11, 2005 and is headquartered in Fukuoka, Japan. | Comptroller/Controller/Auditor | 04/05/2010 |
Hori & Co.
Hori & Co. Recreational ProductsConsumer Durables Hori & Co. is a Japanese company that manufactures gaming accessories. The private company is based in Toyonaka, Japan. The company was founded by Yoshiro Hori. | Fondateur | 01/01/2005 |
Fukuoka Audit Corp.
Fukuoka Audit Corp. Miscellaneous Commercial ServicesCommercial Services Fukuoka Audit Corp. is a private company that provides accounting and investment advice. The company is based in Fukuoka, Japan. | Directeur/Membre du Conseil | 01/01/2000 |
Fukuoka University | Directeur/Membre du Conseil | 01/12/2014 |
Anciens postes connus de Yoshiro Hori
Sociétés | Poste | Fin |
---|---|---|
AQUA Therapeutics Co., Ltd.
AQUA Therapeutics Co., Ltd. Pharmaceuticals: MajorHealth Technology AQUA Therapeutics Co., Ltd. develops therapeutic drugs focused on the treatment of ophthalmological diseases. It uses a nucleic acid interference platform aimed at gene targets of select diseases. The firm's technologies include diabetic retinopathy, Periostin, and Bonac nucleic acid. It also offers research, development, manufacture, and marketing of other pharmaceuticals; non-medicinal products and cosmetics; and medical devices, instruments, and equipment. The firm also conducts medical research and consulting services. The company was founded by Kazunori Yoshikawa on March 19, 2012 and is headquartered in Kobe, Japan. | Comptroller/Controller/Auditor | - |
JM Technology, Inc.
JM Technology, Inc. Engineering & ConstructionIndustrial Services JM Technology, Inc. provides software development and the design and development of hardware solutions. It operates through Information Technology and semiconductor segments. The Information Technology segment develops web systems, infrastructure systems, semiconductor communication control systems, and factory automation and production control systems. The Semiconductor segment offers customized services such as semiconductor manufacturing equipment setup, repairs and maintenance. The company was founded on March 1, 1995 and is headquartered in Fukuoka, Japan. | Directeur/Membre du Conseil | - |
Formation de Yoshiro Hori
Kyushu University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
JTC INC. | Retail Trade |
Entreprise privées | 5 |
---|---|
Aqumen Biopharmaceuticals KK
Aqumen Biopharmaceuticals KK Pharmaceuticals: MajorHealth Technology Aqumen Biopharmaceuticals KK is a holding company that provides research and development of therapeutic medicines for macular degeneration. It also develops therapeutics for diabetic retinopathy, diabetic nephropathy, adjuvants for ophthalmic surgery, and intraocular drug delivery systems. The firm's products encompass the ILM-Blue and the MembraneBlue-Dual. The company was founded by Kimihiko Fujisawa and Tadahisa Kagimoto on April 11, 2005 and is headquartered in Fukuoka, Japan. | Health Technology |
Hori & Co.
Hori & Co. Recreational ProductsConsumer Durables Hori & Co. is a Japanese company that manufactures gaming accessories. The private company is based in Toyonaka, Japan. The company was founded by Yoshiro Hori. | Consumer Durables |
Fukuoka Audit Corp.
Fukuoka Audit Corp. Miscellaneous Commercial ServicesCommercial Services Fukuoka Audit Corp. is a private company that provides accounting and investment advice. The company is based in Fukuoka, Japan. | Commercial Services |
JM Technology, Inc.
JM Technology, Inc. Engineering & ConstructionIndustrial Services JM Technology, Inc. provides software development and the design and development of hardware solutions. It operates through Information Technology and semiconductor segments. The Information Technology segment develops web systems, infrastructure systems, semiconductor communication control systems, and factory automation and production control systems. The Semiconductor segment offers customized services such as semiconductor manufacturing equipment setup, repairs and maintenance. The company was founded on March 1, 1995 and is headquartered in Fukuoka, Japan. | Industrial Services |
AQUA Therapeutics Co., Ltd.
AQUA Therapeutics Co., Ltd. Pharmaceuticals: MajorHealth Technology AQUA Therapeutics Co., Ltd. develops therapeutic drugs focused on the treatment of ophthalmological diseases. It uses a nucleic acid interference platform aimed at gene targets of select diseases. The firm's technologies include diabetic retinopathy, Periostin, and Bonac nucleic acid. It also offers research, development, manufacture, and marketing of other pharmaceuticals; non-medicinal products and cosmetics; and medical devices, instruments, and equipment. The firm also conducts medical research and consulting services. The company was founded by Kazunori Yoshikawa on March 19, 2012 and is headquartered in Kobe, Japan. | Health Technology |